Search This Blog

Tuesday, January 9, 2024

Apellis: Strong prelims

 

  • Approximately $114 million in preliminary fourth quarter SYFOVRE® revenue as strong launch continues
  • Approximately $24 million in preliminary fourth quarter EMPAVELI® revenue  

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.